Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplanin.
Twenty-five febrile patients with a history of intravenous drug use who were receiving either vancomycin (15 patients) or teicoplanin (10 patients) as part of a multicenter, double-blind, randomized, clinical efficacy trial were enrolled, upon receipt of their first dose of antibiotic, into a study...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1992
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC190318/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1384423/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.6.1204 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|